Lv1
40 积分 2022-01-25 加入
Current progress in pathway-targeted therapeutics for Alzheimer’s disease: mechanistic insights and windows of opportunity
2个月前
已完结
Tau-targeting therapies for Alzheimer disease: current status and future directions
2个月前
已完结
Advances in the pharmaceutical development of antibody-oligonucleotide conjugates
4个月前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
5个月前
已完结
Remibrutinib in Chronic Spontaneous Urticaria
7个月前
已完结
Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)
11个月前
已完结
皖公网安备34019202002308
